BioCentury
ARTICLE | Company News

Xoma management update

January 16, 2012 8:00 AM UTC

Xoma Corp. (NASDAQ:XOMA), Berkeley, Calif. Business: Antibodies, Endocrine/Metabolic, Autoimmune Transitioning: John Varian, a director, to CEO from interim CEO ...